Coupling of hypotensive and anit-Parkinson effects with two dopaminergic drugs.
D001058:Apomorphine / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D001921:Brain / Q000187:drug effects; D002230:Carbidopa / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007022:Hypotension / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D002230:Carbidopa; D001058:Apomorphine